Rakovina Therapeutics to Present ATR Inhibitor Data at EORTC-NCI-AACR Symposium
Rakovina Therapeutics says it will present ATR inhibitor data in PTEN-deficient prostate cancer at the 38th EORTC-NCI-AACR Symposium.
Rakovina Therapeutics says it will present ATR inhibitor data in PTEN-deficient prostate cancer at the 38th EORTC-NCI-AACR Symposium.